SLU-PP-332 5mg

SLU-PP-332

Product Name: SLU-PP-332

Research Category: Estrogen-Related Receptor (ERR) Agonist / Metabolic Research Compound

Compound Type: Synthetic Small-Molecule Research Compound (Not a Peptide)

Research Target: Estrogen-Related Receptors (ERRs), including ERRα

Research Interest: Mitochondrial function, oxidative metabolism, cellular energy expenditure, skeletal-muscle metabolism, lipid metabolism, and exercise-associated signaling.

Description

SLU-PP-332 is an experimental small-molecule research compound investigated as an agonist of estrogen-related receptors (ERRs). These nuclear receptors are involved in the regulation of mitochondrial function, oxidative metabolism, and cellular energy homeostasis. Research on SLU-PP-332 has primarily been conducted in preclinical models.

Mechanism of Research

SLU-PP-332 is studied for its ability to activate ERR signaling pathways. Estrogen-related receptors regulate the expression of genes associated with mitochondrial activity, oxidative phosphorylation, fatty-acid oxidation, and cellular energy metabolism. Activation of these pathways is being investigated for its effects on metabolic and skeletal-muscle physiology.

Research Applications

Preclinical research involving SLU-PP-332 includes mitochondrial bioenergetics, oxidative metabolism, fatty-acid utilization, skeletal-muscle physiology, energy expenditure, endurance-associated pathways, and metabolic adaptation.

Storage

Storage requirements depend on the formulation and supplier. Research material should be stored according to the accompanying certificate of analysis (COA), safety data sheet (SDS), and manufacturer specifications.

Research Use Disclaimer

SLU-PP-332 is an experimental research compound and is not an approved therapeutic product. It is not a peptide. Information provided here is for scientific and research reference purposes only and should not be interpreted as medical, prescribing, or dosing advice.